Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Hyperlipoproteinemia Type III

Known as: Broad-beta Hyperlipoproteinemia, HYPERLIPIDEMIA TYPE III, carbohydrate hyperlipemia induced 
An autosomal recessively inherited disorder characterized by the accumulation of intermediate-density lipoprotein (IDL or broad-beta-lipoprotein… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2004
Review
2004
Context Many studies investigate relationships between apolipoprotein E (apoE) polymorphisms and coronary heart disease (CHD… Expand
Review
2000
Review
2000
First recognized as a major determinant in lipoprotein metabolism and cardiovascular disease, apolipoprotein (apo) E has emerged… Expand
Review
1999
Review
1999
Type III hyperlipoproteinemia (HLP) is a genetic disorder characterized by accumulation of remnant lipoproteins in the plasma and… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
1998
Highly Cited
1998
To study isoform-specific effects of apolipoprotein E (apoE) in vivo, we generated mice with a human APOE*2 allele in place of… Expand
  • figure 1
  • table I
  • figure 2
  • figure 3
Highly Cited
1993
Highly Cited
1993
We have developed a simple, rapid assay method for apo E-rich lipoproteins (d < 1.006 g/ml), using an immunoaffinity gel mixture… Expand
Review
1988
Review
1988
Apolipoprotein E is a plasma protein that serves as a ligand for low density lipoprotein receptors and, through its interaction… Expand
Review
1988
Review
1988
The apo E locus contributes to determining the variation in plasma cholesterol levels of healthy and diseased populations. It… Expand
  • figure 1
  • table 1
  • table 3
  • figure 2
  • figure 3
Highly Cited
1975
Highly Cited
1975
Familial hyperlipoproteinemia type III is a primary disorder of lipid metabolism characterized by an elevation of cholesterol and… Expand
Highly Cited
1975
Highly Cited
1975
The clinical and biochemical features of type III hyperlipoproteinemia are described in 49 patients from 23 to 70 years of age… Expand
Highly Cited
1970
Highly Cited
1970
Transport of free fatty acids from the blood into the splanchnic region and their conversion to triglycerides of very low density… Expand
  • table I
  • table I
  • figure 1
  • table I
  • figure 2